GENEVA, Oct. 9 -- K36 THERAPEUTICS, INC. filed a patent application (US2026/022277) for “PIPERIDINYL-METHYL-PURINEAMINE NSD2 INHIBITOR THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING CANCER”. With publication no. WO/2026/213527, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/52
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....